Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer
Condition: Breast Cancer Interventions: Drug: oral vinorelbine; Drug: Capecitabine; Drug: Gemcitabine 1250 mg/m²; Drug: Gemcitabine 1000 mg/m²; Drug: Paclitaxel; Drug: Docetaxel Sponsor: Pierre Fabre Medicament Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Oral Cancer | Research | Study | Taxotere | Xeloda